Influencing factor | Effective group (n = 22) | Less effective group (n = 8) | χ2 | P-value | OR (95%CI) |
---|---|---|---|---|---|
Sex | 0.455 | 0.396 | |||
Male | 14 (63.6) | 4 (50.0) | 1.00 | ||
Female | 8 (36.4) | 4 (50.0) | 1.75 (0.34–8.98) | ||
Age at seizure onset | 0.341 | 0.452 | |||
< 6 months | 14 (63.6) | 6 (75.0) | 1.00 | ||
6 months–1 year | 8 (36.4) | 2 (25.0) | 0.58 (0.09–3.60) | ||
Age at surgery | 2.744 | 0.108 | |||
< 1 year | 10 (45.5) | 1 (12.5) | 1.00 | ||
> 1 year | 12 (54.5) | 7 (87.5) | 5.83 (0.61–55.74) | ||
Seizure duration | 4.224 | 0.047 | |||
Within 1 year | 12 (54.5) | 1 (12.5) | 1.00 | ||
Over 1 year | 10 (45.5) | 7 (87.5) | 8.40 (0.88–80.27) | ||
Etiology | 5.408 | 0.020* | |||
Innate structure | 17 (77.3) | 4 (50.0) | |||
Acquired structure | 5 (22.7) | 1 (12.5) | - | ||
Heredity | 0 (0.0) | 3 (37.5) | |||
Seizure type | 2.078 | 0.161 | |||
Epileptic spasm | 5 (22.7) | 4 (50.0) | 1.00 | ||
Combined with other types of seizure | 17 (77.3) | 4 (50.0) | 0.29 (0.05–1.62) | ||
MRI | 0.545 | 0.405 | |||
Positive | 19 (86.4) | 6 (75.0) | 1.00 | ||
Negative | 3 (13.6) | 2 (25.0) | 2.11 (0.28–15.77) | ||
PET-MRI | 5.514 | 0.048 | |||
Positive | 21 (95.5) | 5 (62.5) | 1.00 | ||
Negative | 1 (4.5) | 3 (37.5) | 12.6 (1.07–148.13) | ||
Surgery type | 3.996 | 0.046* | |||
Hemispherectomy | 10 (45.5) | 3 (37.5) | - | ||
One lobe/multilobar resection | 12 (54.5) | 1 (12.5) | |||
Palliative operation | 0 (0.0) | 4 (50.0) | |||
Lesion location | 12.692 | 0.003 | |||
Focal/unilaterality | 22 (84.6) | 4 (15.4) | 1.00 | ||
Bilateral | 0 (0.0) | 4 (15.4) | 0.15 (0.06–0.38) |